Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations
- PMID: 27311520
- DOI: 10.1016/j.jacc.2016.03.572
Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations
Abstract
Background: Blood pressure (BP) targets from the SPRINT (Systolic Blood Pressure Intervention Trial) differ from targets of the 2014 hypertension (HTN) recommendations of the Eighth Joint National Committee.
Objectives: The goal of this study was to estimate the proportion of hypertensive adults with who would meet BP goals under the SPRINT criteria and under the 2014 recommendations, and to determine related effects on cardiovascular morbidity and mortality.
Methods: We used data from the Korean National Health and Nutrition Examination Survey of 2008 to 2013 (n = 13,346), as well as the Korean National Health Insurance Service health examinee cohort of 2007 (n = 67,965), to estimate the proportion of subjects meeting BP goals of each of the criteria. Using data from the Korean National Health Insurance Service health examinee cohort of 2007 (n = 67,965), we compared risks of major cardiovascular events (composite of nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes) associated with different BP control goals.
Results: A substantially lower proportion of hypertensive adults met BP goals of the SPRINT criteria compared with the 2014 recommendations (11.9% vs. 70.8%, respectively). Ten-year predicted cardiovascular risks were lowest in the intensive control group (below SPRINT BP goals), intermediate in the less-intensive group (above SPRINT goals but below 2014 recommendation goals), and highest in the uncontrolled group (above 2014 recommendations) (6.15%, 7.65%, and 9.39%, respectively; p < 0.001). After multivariable adjustment, the less-intensive and uncontrolled groups had a greater risk of major cardiovascular events (hazard ratios 1.17 and 1.62, respectively; p value for trend, <0.001) than the intensive group.
Conclusions: Substantially fewer hypertensive adults would meet SPRINT BP goals than would meet 2014 recommendation goals. Stricter BP control is associated with a decreased risk of major cardiovascular events.
Keywords: blood pressure; cardiovascular events; hypertension.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Potential Implications of the Systolic Blood Pressure Intervention Trial in Korea.J Am Coll Cardiol. 2016 Jun 21;67(24):2832-4. doi: 10.1016/j.jacc.2016.04.010. J Am Coll Cardiol. 2016. PMID: 27311521 No abstract available.
Similar articles
-
Treatment of Hypertension: Which Goal for Which Patient?Adv Exp Med Biol. 2017;956:117-127. doi: 10.1007/5584_2016_97. Adv Exp Med Biol. 2017. PMID: 27722961 Review.
-
Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).Circulation. 2017 Apr 25;135(17):1617-1628. doi: 10.1161/CIRCULATIONAHA.116.025322. Epub 2017 Feb 13. Circulation. 2017. PMID: 28193605 Free PMC article.
-
Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.Diabetes Care. 2018 Jun;41(6):1142-1148. doi: 10.2337/dc17-1722. Epub 2017 Dec 6. Diabetes Care. 2018. PMID: 29212825
-
Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.JAMA Netw Open. 2021 Feb 1;4(2):e2037554. doi: 10.1001/jamanetworkopen.2020.37554. JAMA Netw Open. 2021. PMID: 33595663 Free PMC article.
-
BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?Curr Cardiol Rep. 2016 Oct;18(10):98. doi: 10.1007/s11886-016-0775-0. Curr Cardiol Rep. 2016. PMID: 27566331 Review.
Cited by
-
Asthma and increased risk of myocardial infarction and mortality among hypertensive Korean patients.Hypertens Res. 2023 Jul;46(7):1694-1704. doi: 10.1038/s41440-023-01257-3. Epub 2023 Mar 29. Hypertens Res. 2023. PMID: 36991063
-
Achievements of primary prevention targets in individuals with high risk of cardiovascular disease: an 8-year follow-up of the Tromsø study.Eur Heart J Open. 2022 Sep 22;2(5):oeac061. doi: 10.1093/ehjopen/oeac061. eCollection 2022 Sep. Eur Heart J Open. 2022. PMID: 36284643 Free PMC article.
-
Circadian Regulation of Blood Pressure: of Mice and Men.Curr Hypertens Rep. 2020 May 21;22(6):40. doi: 10.1007/s11906-020-01043-3. Curr Hypertens Rep. 2020. PMID: 32440958 Free PMC article. Review.
-
Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban.J Am Heart Assoc. 2020 Mar 3;9(5):e009530. doi: 10.1161/JAHA.118.009530. Epub 2020 Feb 21. J Am Heart Assoc. 2020. PMID: 32079476 Free PMC article.
-
Fixed and Low-Dose Combinations of Blood Pressure-Lowering Agents: For the Many or the Few?Drugs. 2019 Nov;79(17):1831-1837. doi: 10.1007/s40265-019-01209-7. Drugs. 2019. PMID: 31602564 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
